- Home
- PRTS vs ACRV Comparison
PRTS vs ACRV Comparison
Compare PRTS & ACRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTS
- ACRV
- Stock Information
- Founded
- PRTS 1995
- ACRV 2018
- Country
- PRTS United States
- ACRV United States
- Employees
- PRTS N/A
- ACRV N/A
- Industry
- PRTS Auto & Home Supply Stores
- ACRV Medicinal Chemicals and Botanical Products
- Sector
- PRTS Consumer Discretionary
- ACRV Health Care
- Exchange
- PRTS Nasdaq
- ACRV Nasdaq
- Market Cap
- PRTS 40.0M
- ACRV 47.8M
- IPO Year
- PRTS 2007
- ACRV 2022
- Fundamental
- Price
- PRTS $0.64
- ACRV $1.81
- Analyst Decision
- PRTS Hold
- ACRV Buy
- Analyst Count
- PRTS 1
- ACRV 6
- Target Price
- PRTS $0.70
- ACRV $17.75
- AVG Volume (30 Days)
- PRTS 967.9K
- ACRV 466.4K
- Earning Date
- PRTS 10-28-2025
- ACRV 11-12-2025
- Dividend Yield
- PRTS N/A
- ACRV N/A
- EPS Growth
- PRTS N/A
- ACRV N/A
- EPS
- PRTS N/A
- ACRV N/A
- Revenue
- PRTS $577,614,000.00
- ACRV N/A
- Revenue This Year
- PRTS N/A
- ACRV N/A
- Revenue Next Year
- PRTS $2.62
- ACRV $805.34
- P/E Ratio
- PRTS N/A
- ACRV N/A
- Revenue Growth
- PRTS N/A
- ACRV N/A
- 52 Week Low
- PRTS $0.64
- ACRV $1.05
- 52 Week High
- PRTS $1.42
- ACRV $8.74
- Technical
- Relative Strength Index (RSI)
- PRTS 35.74
- ACRV 56.14
- Support Level
- PRTS $0.64
- ACRV $1.69
- Resistance Level
- PRTS $0.70
- ACRV $2.04
- Average True Range (ATR)
- PRTS 0.02
- ACRV 0.14
- MACD
- PRTS -0.00
- ACRV -0.01
- Stochastic Oscillator
- PRTS 1.24
- ACRV 43.63
About PRTS CarParts.com Inc.
CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. It serves as an end-to-end solution for automotive repair and maintenance resources, offering a seamless online shopping experience that empowers drivers along every part of their journey. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.